Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Venkatakrishnan

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Applied Optics|March 14, 2008
Scanning laser differential-heterodyne interferometer for flying-height measurementB K Ngoi, K Venkatakrishnan, B Tan
Clinical Pharmacology and Therapeutics|June 3, 2015
Physiologically based and population PK modeling in optimizing drug development: A predict-learn-confirm analysisA Suri, S Chapel, C Lu, et al.
Biosensors & Bioelectronics|January 19, 2012
Femtosecond laser nanostructuring for femtosensitive DNA detectionM Alubaidy, L Soleymani, K Venkatakrishnan, et al.
Applied Optics|April 18, 2002
Phase-shifting interferometry immune to vibrationB K Ngoi, K Venkatakrishnan, N R Sivakumar
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2007
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessmentK Venkatakrishnan, R S Obach, A Rostami-Hodjegan
Peptides|November 11, 1998
Identification of glycine-extended CCK peptides in endocrine cells and modulation of CCK amide and CCK Gly content and secretion from endocrine tumor cells by an inhibitor of amidationM C Beinfeld, M D Perloff, K Venkatakrishnan
Journal of Clinical Pharmacology|June 4, 1999
Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugsK Venkatakrishnan, L L von Moltke, D J Greenblatt
Journal of Pharmaceutical Sciences|April 3, 1999
Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activityK Venkatakrishnan, L L von Moltke, D J Greenblatt
Optics Express|May 7, 2009
The effect of Rowland ghost on sub-micromachining using Femtosecond pulsed laserB K Ngoi, K Venkatakrishnan, B Tan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2000
CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitorK Venkatakrishnan, L L von Moltke, D J Greenblatt
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Applied Optics|March 14, 2008
Scanning laser differential-heterodyne interferometer for flying-height measurementB K Ngoi, K Venkatakrishnan, B Tan
Clinical Pharmacology and Therapeutics|June 3, 2015
Physiologically based and population PK modeling in optimizing drug development: A predict-learn-confirm analysisA Suri, S Chapel, C Lu, et al.
Biosensors & Bioelectronics|January 19, 2012
Femtosecond laser nanostructuring for femtosensitive DNA detectionM Alubaidy, L Soleymani, K Venkatakrishnan, et al.
Applied Optics|April 18, 2002
Phase-shifting interferometry immune to vibrationB K Ngoi, K Venkatakrishnan, N R Sivakumar
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2007
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessmentK Venkatakrishnan, R S Obach, A Rostami-Hodjegan
Peptides|November 11, 1998
Identification of glycine-extended CCK peptides in endocrine cells and modulation of CCK amide and CCK Gly content and secretion from endocrine tumor cells by an inhibitor of amidationM C Beinfeld, M D Perloff, K Venkatakrishnan
Journal of Clinical Pharmacology|June 4, 1999
Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugsK Venkatakrishnan, L L von Moltke, D J Greenblatt
Journal of Pharmaceutical Sciences|April 3, 1999
Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activityK Venkatakrishnan, L L von Moltke, D J Greenblatt
Optics Express|May 7, 2009
The effect of Rowland ghost on sub-micromachining using Femtosecond pulsed laserB K Ngoi, K Venkatakrishnan, B Tan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2000
CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitorK Venkatakrishnan, L L von Moltke, D J Greenblatt
Pageof 5